Enso Capital is a cross-border Healthcare Advisory Firm and an Venture Capital Firm, based in Shanghai P.R.China.
We currently focus on Healthcare Technology or Medtech opportunity。 With our platform and Global Fellow Network, we aim to bring more industry changeing assets to global Venture Capital/ Private Equity firms and Listed Companies.
恩颂资本是一家位于中国上海的专注于医疗产业咨询和投资的公司。
我们当下专注于医疗科技行业。运用我们的平台和全球Fellow网络，我们致力于将可以改变医疗行业的技术与资方（风险与私募基金，成长期与上市公司）链接起来。
Company Details
- Employees
- 9
- Founded
- -
- Address
- No.8 Huaihai Road, F26,china
- Industry
- Financial Services
- NAICS
-
Finance and InsuranceMonetary Authorities-Central Bank
- Website
- enso-fintech.com
- Keywords
- Medtech, cross-boarder investment, Merger & Acquisitions, Equity Investment, Angel Investment, Medical Device, Due Diligence, China Market Entry, Joint Venture, Licensing in, Technology.
- HQ
- Shanghai, Non-U.S.
Enso Capital 恩颂资本 Questions
Enso Capital 恩颂资本's website is enso-fintech.com
Enso Capital 恩颂资本's LinkedIn profile is https://cn.linkedin.com/company/ensocapital
Enso Capital 恩颂资本 has
9 employees.
View email and phone details for 9
employees at Enso Capital 恩颂资本.
Enso Capital 恩颂资本's industry is
Financial Services
Enso Capital 恩颂资本's top competitors are
Canary Data,
Avotres Inc.,
Idac Inc.,
Mashang Consumer Finance,
Consumerpay,
Super Processor,
Payment Ventures, Llc.,
Luma Group,
Dodo,
Vishwa Ltd..
Enso Capital 恩颂资本's categories are Financial Services
Enso Capital 恩颂资本's founding year is 2018
